BDP Week Covers Bioprocessing Methods

Published on: 

Conference sessions, keynote events, exhibits, and poster sessions cover different aspects of bioprocessing.

IBC's Biopharmaceutical Development & Production (BDP) Week event, scheduled for March 24-27, 2014 at the Hilton Bayfront Hotel in San Diego, provides in-depth coverage of bioprocessing methods, to give drug developers tools to develop and manufacture the complex molecules emerging in the biopharmaceutical pipeline.

The event will provide information about challenges and successes in process development and clinical/commercial manufacturing for a wide variety of molecules including mAbs, vaccines, ADCs, recombinant proteins, bispecifics, enzymes, biosimilars, and cell/gene therapy products. Registration gives participants access to several networking opportunities including poster sessions, interactive discussions, and the BDP Week Beach party.

Participants can create an agenda by choosing sessions from nine conference tracks; learn about biopharmaceutical trends from keynote speakers to make development and manufacturing operations more efficient; hear best practice information and real-world experiences from conference sessions featuring 48 case studies and 65 new data presentations; gain knowledge of the key stages of bioprocessing by participating in one of four, 2-day training courses; share research results and discuss industry issues by presenting a poster during the poster sessions; network with fellow attendees, speakers, and exhibitors by using BDP Connect, the conference app and partnering tool ; and, evaluate bioprocessing technology and services needs in the BDP Week exhibit hall featuring more than 65 exhibitors.

The event features nine conference tracks:

  • Antibody Development & Production – Upstream

  • Antibody Development & Production – Downstream

  • Contract Manufacturing & Technology Transfer

  • Process Validation and Continued Process Verification

  • Manufacturing Efficiencies: Strategy and Technology

  • Antibody Drug Conjugate Development & Production

  • Analytical Technologies for Biotherapeutic Development

  • Viral Safety for Biologicals

  • Raw Materials/ Supply Chain Management & Transparency

The event will also feature sixe keynote addresses:

  • Lifecycle Management, Joanne T. Beck, PhD, vice president, Process Development, and Manufacturing Science, Shire
  • Contamination Prevention Matthew Croughan, PhD, industry professor, Amgen Bioprocessing Center and founding professor, Bioprocessing Program, Keck Graduate Institute

  • Drug Quality, Jeffrey C. Baker, PhD, deputy director, Office of Biotechnology Products (OBP), Center for Drug Evaluation and Research, FDA

  • Flexible Bioproduction, R. Thomas Warf, director, Manufacturing, Facilities and Engineering, BARDA, US Department of Health & Human Services

  • Integration & Innovation, Jens H. Vogel, PhD, executive director and head, Process Science USA, Boehringer Ingelheim
  • Innovative Manufacturing, Tina M. Larson, senior director, Technical Development Operations & Engineering, Genentech, Inc.

In addition, four, two-day training courses are being held: Introduction to Biopharmaceutical Manufacturing; CMC Analytical, Comparability, and Stability Studies; Introduction to Downstream Processing in Biomanufacturing; and Cell Culture and Fermentation Bioprocessing

Special Biopharm International Magazine Savings: To save 20% off the standard rates register with priority code BDP14BI. Register online at:  or by calling 800.390.4078.  This offer is only available for new registrations and cannot be combined with other offers.